Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellebrite DI (CLBT) Capital Expenditures (2020 - 2025)

Cellebrite DI's Capital Expenditures history spans 6 years, with the latest figure at -$4.0 million for Q4 2025.

  • Quarterly Capital Expenditures fell 24.48% to -$4.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$13.2 million through Dec 2025, down 54.39% year-over-year, with the annual reading at $13.2 million for FY2025, 54.39% up from the prior year.
  • Capital Expenditures came in at -$4.0 million for Q4 2025, down from -$3.3 million in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $749000.0 in Q4 2021 to a low of -$4.0 million in Q4 2025.
  • The 5-year median for Capital Expenditures is -$1.2 million (2022), against an average of -$1.4 million.
  • Year-over-year, Capital Expenditures soared 1024.69% in 2021 and then plummeted 1469.62% in 2023.
  • Cellebrite DI's Capital Expenditures stood at $749000.0 in 2021, then crashed by 285.71% to -$1.4 million in 2022, then plummeted by 62.47% to -$2.3 million in 2023, then tumbled by 40.62% to -$3.2 million in 2024, then fell by 24.48% to -$4.0 million in 2025.
  • Per Business Quant, the three most recent readings for CLBT's Capital Expenditures are -$4.0 million (Q4 2025), -$3.3 million (Q3 2025), and -$3.6 million (Q2 2025).